Differential STAT3, STAT5, and NF-κB activation in human hematopoietic progenitors by endogenous interleukin-15: Implications in the expression of functional molecules

Blood

Volumn 102, Issue 1, 2003, Pages 109-117

  Giron Michel, Julien ^b   Caignard, Anne ^b   Fogli, Manuela ^b   Brouty Boyé, Danièle ^b   Briard, Diane ^b   Van Dijk, Marc ^b   Meazza, Raffaella ^b   Ferrini, Silvano ^b   Lebousse Kerdilès, Caroline ^b   Clay, Denis ^b   Bompais, Heidi ^b   Chouaib, Salem ^b   Péault, Bruno ^b   Azzarone, Bruno ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN RECEPTOR; MONOCLONAL ANTIBODY; STAT3 PROTEIN; STAT5 PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; AUTOCRINE EFFECT; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

EID: 0038644731     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-09-2760     Document Type: Article

References (59)

1. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol. 1999;17:19-49.
2. Fehniger TA, Caligiuri MA. Interieukin 15: biology and relevance to human disease. Blood. 2001;97:14-32.
3. Meazza R, Verdiani S, Biassoni R, et al. Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene. 1996;12:2187-2192.
4. Onu A, Pohl S, Krause H, Bulfone-Paus S. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J Immunol. 1997;158:255262.
5. Tagaya Y, Kurys G, Ahies T, et al. Generation of secretable and rionsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc Natl Acad Sci U S A. 1997;94:14444-14449.
6. Meazza R, Gaggero, Neglia F, et al. Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides. Eur J Immunol. 1997;27:1049-1054.
7. Gaggero A, Azzarone B, Andrei C, et al. Differential intracellular trafficking, secretion and endosomal localization of two IL-15 isoforms. Eur J Immunol. 1999;4:1265-1274.
8. Musso T, Calosso L, Zucca M, et al. Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood. 1999;93:3531-3539.
9. Nishimura H, Yajima T, Naiki Y, et al. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J Exp Med. 2000;191:157-170.
10. Anderson D, Kumaki S, Ahdieh M, et al. Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL-15Rα and IL-2Rα genes. J Biol Chem. 1995; 270:29862-29869.
11. Dubois S, Magrangeas F, Lehours P, et al. Natural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expression. J Biol Chem. 1999;274:26978-26984.
12. Tagaya Y, Burton JD, Miyamoto Y, Waidmann TA. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J. 1996;15:4928-4939.
13. McDonald PP, Russo MP, Ferrini S, Cassatella MA. Interleukin-15 (IL-15) induces NF-κB activation and IL-8 production in human neutrophils. Blood. 1998;92:4828-4835.
14. Bulfone-Paus S, Bulanova E, Pohl T, et al. Death deflected: IL-15 inhibits TNF-α-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL15Rα chain. FASEB J. 1999;13:1575-1585.
15. Masuda A, Matsuguchi T, Yamaki K, et al. Interleukin-15 induces rapid tyrosine phosphorylation of STAT6 and the expression of interleukin-4 in mouse mast cells. J Biol Chem. 2000;275:29331-29337.
16. Cavazzana-Calvo M, Hacein-Bey S, De Saint Basile G, et al. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells. Blood. 1996;88:3901-3909.
17. Carayol G, Robin C, Bourhis JH, et al. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions. Eur J Immunol. 1998;28:1991-2002.
18. Bykovskaia SN, Buffo M, Zhang H, et al. The generation of human dendritic and NK cells from hemopoietic progenitors induced by interleukin-15. J Leuk Biol. 1999;66:659-666.
19. Pierelli L, Scambia G, Bonanno G, et al. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15. Exp Hematol. 1999;27:416-424.
20. Lin SJ, Yang MH, Chao HC, Kuo ML, Huang JL. Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells. Pediatr Allergy Immunol. 2000;11:168-174.
21. Yu H, Fehniger TA, Fuchshuber P, et al. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood. 1998;92:3647-3657.
22. Carayol G, Giron-Michel J, Azzarone B, et al. Altered natural killer cell differentiation in CD34+ progenitors from chonic myeloid leukemia patients. Oncogene. 2000;19:2758-2766.
23. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med. 1997;185:111-120.
24. Lataillade JJ, Clay D, Bourin P, et al. Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood. 2002;99:1117-1129.
25. Funk PE, Kincade PW, Witte PL, et al. Native associations of early hematopoietic stem cells and stromal cells isolated in bone marrow cell aggregates. Blood. 1994;83:361-369.
26. Prosper F, Stroncek D, McCarthy JB, Verfaillie CM. Mobilization and homing of peripheral blood progenitors is related to reversible down regulation of α4β1 integrin expression and function. J Clin Invest. 1998;101:2456-2467.
27. Szilvassy SJ, Meyerrose TE, Ragland PL, Grimes B. Homing and engraftment defects in ex vivo expanded murine hematopoietic cells are associated with down-regulation of beta1 integrin. Exp Hematol. 2001;29:1494-1502.
28. Ohbo, K, Asao H, Kouro T, et al. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood. 1996;87:956-967.
29. Grossman WJ, Verbsky JW, Yang L, et al. Dysregulated myelopoiesis in mice lacking Jak3. Blood. 1999;94:932-939.
30. Itano M, Tsuchiya S, Morita S, et al. IL-2 receptor gamma chain expression on CD34 positive hematopoietic progenitor cells from bone marrow and cord blood. J Exp Med. 1996;78:389-398.
31. Le Bousse-Kerdiles MC, Chevillard S, Charpentier A, et al. Differential expression of transforming growth factor-β, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood. 1996;88:4534-4546.
32. Pech N, Olivier H, Goldwasser E. Further study of internal autocrine regulation of multipotent hematopoietic cells. Blood. 1993;82:1502-1506.
33. Schibler KR, Li Y, Ohls RK, et al. Possible mechanisms accounting for the growth factor independence of hematopoietic progenitors from umbilical cord blood. Blood. 1994;84:3679-3684.
34. Watari K, Lansdorp P, Dragowska W, Mayani H, Schader JW. Expression of interleukin-1 in candidate human hematopoietic stem cells. Blood. 1994;84:36-42.
35. Ratajczak M, Kuczynski W, Sokol D, Moore J, Pletcher C, Gewirtz AM. Expression and physiologic significance of kit ligand and stem cell tyrosine kinase-1 receptor ligand expression in normal human CD34+, c-Kit R+ marrow cells. Blood. 1995;86:2161-2167.
36. Behinger D, Kresin V, Henschler R, Mertelsmann R, Lindermann A. Cytokine and chemokine production by CD34+ haematopoietic progenitor cells: detection in single cells. Br J Haematol. 1997;97:9-14.
37. Stopka T, Zivny JH, Stopkova P, Prchal JF, Prchal JT. Human hematopoietic progenitors express erythopoietin. Blood. 1998;91:3766-3772.
38. Majka M, Rozmyslowicz T, Lee B, et al. Bone marrow CD34+ cells and megakaryoblasts secrete beta-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV. J Clin Invest. 1999;104:1739-1749.
39. - cells from thymus, cord, and peripheral blood and bone marrow is explained by their ability to produce beta-chemokines. Exp Hematol. 2000;28:1334-1342.
40. Majka M, Janowska-Wieczorek A, Ratajczak J, et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood. 2001;97:3075-3085.
41. Pereno R, Giron-Michel J, Gaggero A, Cazes E, et al. IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα. Oncogene. 2000;19:5153-5162.
42. Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol. 2001;13:211-217.
43. Barnes PJ, Adcock IM. NF-κB: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci. 1997;18:46-50.
44. Goldfeld AE, Strominger JL, Doyle C. Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines. J Exp Med. 1991;174:73-81.
45. Albrecht H, Schook LB, Jongeneel CV. Nuclear migration of NF-κB correlates with TNF-α mRNA accumulation. J Inflamm. 1995;45:64-71.
46. Bosco MC, Espinoza-Delgado I, Schwabe M, et al. The gamma subunit of the interleukin-2 receptor is expressed in human monocytes and modulated by interleukin-2, interferon gamma, and transforming growth factor beta 1. Blood. 1994;83:3462-3467.
47. Brouty-Boyé D, Briard D, Azzarone B, et al. Effects of human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues on CD34+ stem cells. Int J Cancer. 2001;92: 484-488.
48. Briard D, Brouty-Boye D, Azzarone B, Jasmin C. Fibroblasts from human spleen regulate NK cell differentiation from blood CD34(+) progenitors via cell surface IL-15. J Immunol. 2002;168:4326-4332.
49. Bertolini F, Battaglia M, Lanza A, et al. Hematopoietic stem cells from different sources: biological and technical aspects. Bone Marrow Transplant. 1998;2(suppl):S5-S7.
50. Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol. 1999;27:1418-1427.
51. Noort WA, Willemze R, Falkenburg JH. Comparison of repopulating ability of hematopoietic progenitor cells isolated from human umbilical cord blood or bone marrow cells in NOD/SCID mice. Bone Marrow Transplant. 1998;1(suppl):S58-S60.
52. Qian JX, Lee SM, Suen Y, Knoppel E, van de Ven C, Cairo MS. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in up-regulating antitumor immune activity and cytokine production in cord blood. Blood. 1997;90:3106-3117.
53. Miller JS, Prosper F, McCullar V. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood. 1997;90:3098-3105.
54. Jiang Y, Prosper F, Verfaillie CM. Opposing effects of engagement of integrins and stimulation of cytokine receptors on cell cycle progression of normal human hematopoietic progenitors. Blood. 2000;95:846-854.
55. Hurley RW, McCarthy JB, Wayner EA, Verfaillie CM. Monoclonal antibody crosslinking of the alpha 4 or beta 1 integrin inhibits committed clonogenic hematopoietic progenitor proliferation. Exp Hematol. 1997;25:321-328.
56. Gordon MY, Lewis JL, Marley SB, Grand FH, Goldman JM. Stromal cells negatively regulate primitive haemopoietic progenitor cell activation via a phosphatidylinositol-anchored cell adhesion/signalling mechanism. Br J Haematol. 1997;96:647-653.
57. Roy V, Verfaillie CM. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis. Exp Hematol. 1999;27:302-312.
58. Schumann RR, Nakarai T, Gruss HJ, et al. Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gammachain) by normal and malignant myeloid cells. Blood. 1996;87:2419-2427.
59. Itano M, Tsuchiya S, Morita S, et al. IL-2 receptor gamma chain expression on CD34 positive hematopoietic progenitor cells from bone marrow and cord blood. Tohoku J Exp Med. 1996;178:389-398.